Skip to main content
Home
Zeitschriften
Zeitungen
Podcast
Gesundheitspolitik
Praxis
Allerlei
Jobs
Fachgebiete
Allgemeinmedizin Anästhesiologie & Intensivmedizin Apotheke Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kinder & Jugendheilkunde Neurologie & Psychiatrie Orthopädie & Unfallchirurgie Pflege Urologie Zahnmedizin
Subfächer Innere Medizin
Diabetologie Gastroenterologie Infektiologie Kardiologie Onkologie und Hämatologie Pneumologie Rheumatologie
Fortbildungen
Überblick Fortbildungen DFP-Literaturstudium-Artikel DFP-Webcast Fortbildungen DFP-Podcasts
Erweiterte Suche
Anmelden
nach oben
memo - Magazine of European Medical Oncology
Erschienen in:

14.06.2018 | comment

My burning issues in the management of liver metastases of advanced colorectal cancer

verfasst von: Peter Tschann, Stephanie Rauch, Paolo Girotti, Holger Rumpold, Ingmar Königsrainer

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Auszug

Years ago liver metastases of any primary location were mostly treated by chemotherapy only and were associated with a poor prognosis. In the past few years, the surgical management of liver metastasis has received much hype because of new options in preoperative therapy and because of better (sometimes combined) interventional and surgical techniques. Many studies showed that liver metastases (LM) have an influence in long-term prognosis of metastasised diseases [1], especially in case of colorectal cancer liver metastasis (CRLM). …
Vorheriger Artikel Demystification of palliative care: what palliative care teams don’t want you to think about them
Nächster Artikel Current concepts and future directions in neoadjuvant chemotherapy of breast cancer
Literatur
1.
2.
3.
Alvarez FA, Ardiles V, Sanchez Claria R, et al. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): tips and tricks. J Gastrointest Surg. 2013;17:814–21.CrossRefPubMed
4.
Martel G, Cieslak KP, Huang R, van Lienden KP, Wiggers JK, Belblidia A, Dagenais M, Lapointe R, van Gulik TM, Vandenbroucke-Menu F. Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resections. HPB (Oxford). 2015;17(12):1051–7. https://​doi.​org/​10.​1111/​hpb.​12480.CrossRef
5.
6.
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, Hess K, Curley SA. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25. discussion 825–7.CrossRefPubMedPubMedCentral
7.
Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33:62–8.CrossRefPubMedPubMedCentral
8.
van Amerongen MJ, Jenniskens SFM, van den Boezem PB, Futterer JJ, de Wilt JHW. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases—a meta-analysis. HPB (Oxford). 2017;19:749–56.CrossRef
9.
Adam R, Wicherts DA, de Haas RJ, Ciacio O, Levi F, Paule B, Ducreux M, Azoulay D, Bismuth H, Castaing D. Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol. 2009;27:1829–35.CrossRefPubMed
10.
Miller CL, Taylor MS, Qadan M, Deshpande V, Worthington S, Smalley R, Collura C, Ryan DP, Allen JN, Blaszkowsky LS, Clark JW, Murphy JE, Parikh AR, Berger D, Tanabe KK, Lillemoe KD, Ferrone CR. Prognostic significance of surgical margin size after neoadjuvant FOLFOX and/or FOLFIRI for colorectal liver metastases. J Gastrointest Surg. 2017; https://​doi.​org/​10.​1007/​s11605-017-3557-0.PubMedCrossRef
11.
Donadon M, Cescon M, Cucchetti A, Cimino M, Costa G, Pesi B, Ercolani G, Pinna AD, Torzilli G. Parenchymal-sparing surgery for the surgical treatment of multiple colorectal liver metastases is a safer approach than major hepatectomy not impairing patients’ prognosis: a bi-institutional propensity score-matched analysis. Dig Surg. 2017; https://​doi.​org/​10.​1159/​000479336.PubMedCrossRef
12.
Moris D, Ronnekleiv-Kelly S, Kostakis ID, Tsilimigras DI, Beal EW, Papalampros A, Dimitroulis D, Felekouras E, Pawlik TM. Operative results and oncologic outcomes of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis. World J Surg. 2017; https://​doi.​org/​10.​1007/​s00268-017-4181-6.CrossRefPubMed
13.
Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg. 2000;232:777–85.CrossRefPubMedPubMedCentral
14.
15.
Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Horbelt R, Kroemer A, Loss M, Rummele P, Scherer MN, Padberg W, Konigsrainer A, Lang H, Obed A, Schlitt HJ. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2—staged extended right hepatic resection in small-for-size settings. Ann Surg. 2012;255:405–14.CrossRefPubMed
16.
Eshmuminov D, Raptis DA, Linecker M, Wirsching A, Lesurtel M, Clavien PA. Meta-analysis of associating liver partition with portal vein ligation and portal vein occlusion for two-stage hepatectomy. Br J Surg. 2016;103:1768–82.CrossRefPubMed
17.
18.
19.
Zhou Z, Xu M, Lin N, Pan C, Zhou B, Zhong Y. Associating liver partition and portal vein ligation for staged hepatectomy versus conventional two-stage hepatectomy: a systematic review and meta-analysis. World J Surg Oncol. 2017;15:227.CrossRefPubMedPubMedCentral
20.
Hackl C, Brunner SM, Schmidt KM, Schlitt HJ. Chirurgische Innovationen in der Therapie des metastasierten kolorektalen Karzinoms. Die Komplexität der Metastasenchirurgie als Beispiel für personalisierte Medizin. Chirurg. 2018;89(3):191–6.CrossRefPubMed
Metadaten
Titel
My burning issues in the management of liver metastases of advanced colorectal cancer
verfasst von
Peter Tschann
Stephanie Rauch
Paolo Girotti
Holger Rumpold
Ingmar Königsrainer
Publikationsdatum
14.06.2018
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0415-z

Weitere Artikel der Ausgabe 3/2018

Educational no. 2: flow cytometry

  • educational

Post SABCS local therapy and radiology

  • Open Access
  • short review

Still making progress

  • editorial

Role of complement in the pathogenesis of thrombotic microangiopathies

  • review

SABCS 2017: lifestyle factors, hormone receptor-positive advanced disease, liquid biopsies, and prognosis

  • Open Access
  • short review

Current concepts and future directions in neoadjuvant chemotherapy of breast cancer

  • Open Access
  • review